Based on the measurements of operating efficiency obtained from GE HealthCare's historical financial statements, GE HealthCare Technologies is performing exceptionally good at this time. It has a great probability to report excellent financial results in April. At present, GE HealthCare's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 2.6 B, whereas Total Assets are forecasted to decline to about 31.6 B. Key indicators impacting GE HealthCare's financial strength include:
The financial analysis of GE HealthCare is a critical element in measuring its lifeblood. Investors should not minimize GE HealthCare's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
2.35 Billion
GEHC
Select Account or Indicator
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Investments
Change In Cash
Net Borrowings
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Change To Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Common Stock Shares Outstanding
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Net Tangible Assets
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Long Term Debt
Cash And Short Term Investments
Net Receivables
Good Will
Liabilities And Stockholders Equity
Non Current Liabilities Total
Capital Lease Obligations
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Deferred Long Term Liab
Net Invested Capital
Long Term Investments
Property Plant And Equipment Gross
Short Long Term Debt
Total Current Assets
Accumulated Other Comprehensive Income
Capital Stock
Non Current Liabilities Other
Net Working Capital
Short Term Debt
Intangible Assets
Common Stock
Property Plant Equipment
Tax Provision
Net Interest Income
Interest Income
Discontinued Operations
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Reconciled Depreciation
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Income Tax Expense
Minority Interest
Probability Of Bankruptcy
Understanding current and past GE HealthCare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GE HealthCare's financial statements are interrelated, with each one affecting the others. For example, an increase in GE HealthCare's assets may result in an increase in income on the income statement.
Please note, the presentation of GE HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GE HealthCare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of GE HealthCare's management manipulating its earnings.
Comparative valuation techniques use various fundamental indicators to help in determining GE HealthCare's current stock value. Our valuation model uses many indicators to compare GE HealthCare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GE HealthCare competition to find correlations between indicators driving GE HealthCare's intrinsic value. More Info.
GE HealthCare Technologies is one of the top stocks in return on equity category among its peers. It is rated # 4 in return on asset category among its peers reporting about 0.22 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for GE HealthCare Technologies is roughly 4.45 . At present, GE HealthCare's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GE HealthCare's earnings, one of the primary drivers of an investment's value.
GE HealthCare Techno Systematic Risk
GE HealthCare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. GE HealthCare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on GE HealthCare Techno correlated with the market. If Beta is less than 0 GE HealthCare generally moves in the opposite direction as compared to the market. If GE HealthCare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GE HealthCare Techno is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GE HealthCare is generally in the same direction as the market. If Beta > 1 GE HealthCare moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in GE HealthCare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various GE HealthCare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of GE HealthCare growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.43
At present, GE HealthCare's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
GE HealthCare March 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of GE HealthCare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GE HealthCare Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of GE HealthCare Technologies based on widely used predictive technical indicators. In general, we focus on analyzing GEHC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GE HealthCare's daily price indicators and compare them against related drivers.
When running GE HealthCare's price analysis, check to measure GE HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GE HealthCare is operating at the current time. Most of GE HealthCare's value examination focuses on studying past and present price action to predict the probability of GE HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GE HealthCare's price. Additionally, you may evaluate how the addition of GE HealthCare to your portfolios can decrease your overall portfolio volatility.
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance